The UK Investor Magazine Podcast welcomes Andrew Aldridge, a Partner at Deepbridge Capital.
Deepbridge Capital is the manager of a £200 million range of tax-efficient EIS and SEIS funds including the Deepbridge Life Sciences EIS, Deepbridge Life Sciences SEIS and Deepbridge Technology Growth EIS.
Andrew joins the Podcast to focus on their Life Sciences funds which account for roughly £50m of their £200m investments.
We discuss how the pandemic has increased investment in Life Sciences and Health Care as investors seek out opportunities in the evolving health care system.
Andrew highlights a selection of companies Deepbridge have added to their portfolios and the key trends they see developing in the sector.
We explore the most important factors Deepbridge consider when selecting early stage companies for their portfolios and delve into the journey’s of some of their portfolio companies.